mk 436 and arsenic
mk 436 has been researched along with arsenic in 3 studies
Compound Research Comparison
| Studies (mk 436) | Trials (mk 436) | Recent Studies (post-2010) (mk 436) | Studies (arsenic) | Trials (arsenic) | Recent Studies (post-2010) (arsenic) |
|---|---|---|---|---|---|
| 20 | 0 | 0 | 27,806 | 280 | 13,049 |
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Jennings, FW | 3 |
Reviews
1 review(s) available for mk 436 and arsenic
| Article | Year |
|---|---|
Combination chemotherapy of CNS trypanosomiasis.
Topics: Arsenicals; Central Nervous System Diseases; Drug Therapy, Combination; Humans; Melarsoprol; Nitroimidazoles; Trypanocidal Agents; Trypanosomiasis, African | 1993 |
Other Studies
2 other study(ies) available for mk 436 and arsenic
| Article | Year |
|---|---|
Chemotherapy of CNS-trypanosomiasis: combination chemotherapy with a 5-nitroimidazole (MK 436), an arsenical (Cymelarsan) and suramin.
Topics: Animals; Arsenicals; Brain Diseases; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Nitroimidazoles; Suramin; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1991 |
Chemotherapy of CNS-trypanosomiasis: the combined use of the arsenicals and nitro-compounds.
Topics: Animals; Antiprotozoal Agents; Arsenicals; Brain Diseases; Drug Synergism; Drug Therapy, Combination; Female; Ketoconazole; Metronidazole; Mice; Nifurtimox; Nitro Compounds; Nitroimidazoles; Oxidation-Reduction; Suramin; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1991 |